Yes, excellent work Iceman.
I have put LFC on ignore. Not because of his contrary opinions or sentiment although one evening when I suspect he was drunk he directed the most foul and abusive personal attacks against other posters on the forum. Unacceptable.
The update on ADAPT 2 a couple of days ago was excellent although I guess the news we're all really waiting for is the 30 day review of the 5 patients in Georgia who have so far received the DurAVR. Could be any day now. (The 7 day review was released on the 1st of December, we are now 37 days after that.)
Make no mistake, this is a US $Billion+ company in the making.
All that is required (by you, the investor) is patience.
Moving forward., page-2
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.50 |
Change
-0.550(2.61%) |
Mkt cap ! $393.8M | |||
| Open | High | Low | Value | Volume |
| $21.05 | $21.05 | $20.00 | $268.0K | 13.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 492 | $20.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.50 | 1046 | 2 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
| AVR (ASX) Chart |